Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Rituximab

5

X.n Tumor lysis syndrome (TLS)

1
Last update : 12/08/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Anti-CD20 antibody therapy
4

Publications

Rituximab and cytokine release syndrome.
Case reports in oncology 2012 Jan;5;134-41 2012 Jan
Diagnosis and treatment of rituximab-induced acute tumor lysis syndrome in patients with diffuse large B-cell lymphoma.
The American journal of the medical sciences 2012 Apr;343;337-41 2012 Apr
Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
Transplantation proceedings 2009 Jun;41;1946-8 2009 Jun
Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.
International journal of hematology 2005 Nov;82;312-4 2005 Nov

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies